Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir

Journal of Clinical Oncology

Volumn 23, Issue 31, 2005, Pages 7927-7935

  Chévez Barrios, Patricia ^b   Chintagumpala, Murali ^b   Mieler, William ^b   Paysse, Evelyn ^b   Boniuk, Milton ^b   Kozinetz, Claudia ^b   Hurwitz, Mary Y ^b   Hurwitz, Richard L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GANCICLOVIR; THYMIDINE KINASE; ANTIVIRUS AGENT;

ARTICLE; BRACHYTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EDEMA; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG SAFETY; FEASIBILITY STUDY; HERPES SIMPLEX; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; INFLAMMATION; INTRAOCULAR PRESSURE; MEDICAL DOCUMENTATION; OPHTHALMOSCOPY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RETINOBLASTOMA; SIDE EFFECT; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS PARTICLE; VITREOUS BODY; DRUG EFFECT; ENZYMOLOGY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN ADENOVIRUS; IATROGENIC DISEASE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETINA TUMOR; TUMOR RECURRENCE;

ADENOVIRUSES, HUMAN; ANTIVIRAL AGENTS; CHILD; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; RETINAL NEOPLASMS; RETINOBLASTOMA; THYMIDINE KINASE; VITREOUS BODY;

EID: 31644447744     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.00.1883     Document Type: Article

References (31)

1. Devesa S: The incidence of retinoblastoma. Am J Ophthalmol 80:263-265, 1975
2. Margo C, Hidayet A, Kopelman A, et al: Retinocytoma: A benign variant of retinoblastoma. Arch Ophthalmol 101:1519-1531, 1983
3. Knudson AG Jr: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823, 1971
4. Dryja TP, Rapaport JM, Weichselbaum R, et al: Chromosome 13 restriction fragment length polymorphisms. Hum Genet 65:320-324, 1984
5. Harbour JW: Overview of RB gene muta-in patients with retinoblastoma: Implications for clinical genetic screening. Ophthalmology 105: 1442-1447, 1998
6. Shields CL, Shields JA: Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 36:8-18, 1999
7. Gallie BH, Budning A, DeBoer G, et al: Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114:1321-1328, 1996
8. [Erratum: Arch Ophthalmol 115:525, 1997]
9. Murphree AL, Villablanca JG, Deegan WF III, et al: Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114:1348-1356, 1996
10. Roarty JD, McLean IW, Zimmerman LE: Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 95:1583-1587, 1988
11. Abramson DH, Beaverson K, Sangani P, et al: Screening for retinoblastoma: Presenting signs as prognosticators of patient and ocular survival. Pediatrics 112:1248-1255, 2003
12. Shields CL, de Potter P, Himelstein BP, et al: Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330-1338, 1996
13. Trask TW, Trask RP, Aguilar-Cordova E, et al: Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther 1:195-203, 2000
14. Teh BS, Ayala G, Aguilar L, et al: Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer: Interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys 58: 1520-1529, 2004
15. Havlik R, Jiao LR, Nicholls J, et al: Gene therapy for liver metastases. Semin Oncol 29: 202-208, 2002
16. Banerjee D: Technology evaluation: Gene therapy (mesothelioma), NCI. Curr Opin Mol Ther 1:517-520, 1999
17. Sung MW, Yeh HC, Thung SN, et al: Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial. Mol Ther 4:182-191, 2001
18. Alvarez RD, Gomez-Navarro J, Wang M, et al: Adenoviral-mediated suicide gene therapy for ovarian cancer. Mol Ther 2:524-530, 2000
19. Morris JC, Wildner O: Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk. Mol Ther 1:56-62, 2000
20. Hurwitz MY, Marcus KT, Chevez-Barrios P, et al: Suicide gene therapy for treatment of retinoblastoma in a murine model. Hum Gene Ther 10:441-448, 1999
21. Chen SH, Shine HD, Goodman JC, et al: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91:3054-3057, 1994
22. Shields CL, Shields JA, Baez KA, et al: Choroidal invasion of retinoblastoma: Metastatic potential and clinical risk factors. Br J Ophthalmol 77:544-548, 1993
23. Tamboli A, Podgor MJ, Norm JW: The incidence of retinoblastoma in the United States. Arch Ophthalmol 108:128-132, 1990
24. Shields JA: The expanding role of laser photocoagulation for intraocular tumors. The 1993 H. Christian Zweng Memorial Lecture. Retina 14:310-322, 1994
25. Shields CL, Santos MC, Diniz W, et al: Thermotherapy for retinoblastoma. Arch Ophthalmol 117:885-893, 1999
26. Acland GM, Aguirre GD, Ray J, et al: Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28:92-95, 2001
27. Mori K, Gehlbach P, Ando A, et al: Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 43: 2428-2434, 2002
28. Reese AB, Ellsworth RM: Management of retinoblastoma. Ann N Y Acad Sci 114:958-962, 1964
29. Shields CL, Mashayekhi A, Demirci H, et al: Practical approach to management of retinoblastoma. Arch Ophthalmol 122:729-735, 2004
30. Elshami AA, Saavedra A, Zhang H, et al: Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 3:85-92, 1996
31. Herman JR, Adler HL, Aguilar-Cordova E, et al: In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial. Hum Gene Ther 10:1239-1249, 1999